| Shareholders | No of B shares | No of votes | Share of capital, % | Share of votes, % |
| Färna Invest AB | 53,867,579 | 5,386,758 | 49,91% | 49,91% |
| Nexttobe | 31,994,475 | 3,199,448 | 29,65% | 29,65% |
| Varenne | 4,196,026 | 419,603 | 3,89% | 3,89% |
| Others | 17,865,674 | 1,786,567 | 16,55% | 16,55% |
| Total | 107,923,328 | 10,792,333 | 100% | 100% |
Bluefish Pharmaceuticals AB
Gävlegatan 22
SE-113 30 Stockholm, Sweden
Tel: +46 8 5191 1600
Fax: +46 8 5191 1690
info-se@bluefishpharma.com
business.development@bluefishpharma.com
drugreaction@bluefishpharma.com
Tel +46 8 5191 1600
Fax +46 8 5191 1690
E-mail complaints@bluefishpharma.com
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.